Latest Breaking News On - Paul edick - Page 1 : comparemela.com

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United-states
Americans
Xeris-careconnection
Oren-livnat
Kelly-close
Allison-wey
Gvoke-hypopen
Leland-gershell
Xerisol-levothyroxine
John-shannon
Steven-pieper
Paul-edick

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions

Key Insights The considerable ownership by retail investors in Xeris Biopharma Holdings indicates that they.

Paul-edick
Blackrock-inc
Xeris-biopharma-holdings
Xeris-biopharma-holding
Xeris-biopharma-holdings-inc
Xeris-biopharma
Nc
Xeris-biopharma-holdings
Institutional-investors
Retail-investors
Shareholders

Xeris Biopharma inks exclusive worldwide license agreement with Amgen for XeriJect in thyroid eye disease

Xeris Biopharma inks exclusive worldwide license agreement with Amgen for XeriJect in thyroid eye disease
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Paul-edick
Xeri-xeriject
Amgen
Xeris-biopharma-holdings
Thyroid-eye-disease

Xeris Biopharma Holdings Shares Jump 14% on Raised 2023 Outlook

By Denny Jacob Xeris Biopharma Holdings shares jumped 14%, to $2.56, after the biopharmaceutical company raised part of its outlook for 2023. The stock has.

Denny-jacob
Paul-edick
Xeris-biopharma-holdings
Biopharma-holdings
Chief-executive-paul
Article-normal
Biotechnology-services
Pharmaceuticals
Healthcare-life-sciences
Biopharmaceuticals
Financial-performance
Share-price-movement-disruptions

Xeris Biopharma updates FY23 outlook; remains on track for 4Q positive cash flow

Xeris Biopharma updates FY23 outlook; remains on track for 4Q positive cash flow
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

San-francisco
California
United-states
Paul-edick
Xeris-biopharma-holdings